Features of comprehensive diagnostics of Crohn’s disease in pediatric practice

Authors

DOI:

https://doi.org/10.14739/2310-1237.2025.1.312416

Keywords:

ulcerative colitis, Crohn’s disease, inflammatory bowel disease, diagnosis, pathohistological examination

Abstract

Inflammatory bowel diseases, particularly Crohn’s disease and ulcerative colitis, represent some of the most challenging conditions in contemporary gastroenterology. These disorders are associated with significant complications and a high tendency toward chronicity. Onset typically occurs during childhood or early adulthood. The immune system plays a central role in the pathogenesis of inflammatory bowel diseases; however, the precise mechanisms involved remain incompletely understood. It is well established that dysregulation of the immune response to the intestinal microbiota is a key factor contributing to the development of chronic inflammation.

Aim: to demonstrate the features and challenges of diagnosing Crohn’s disease in children.

Material and methods. The case of an 11-year-old girl who was admitted to the hospital with symptoms of systemic inflammation, abdominal pain, hepatomegaly, and other signs mimicking a viral-bacterial infection is presented. Laboratory tests and endoscopy revealed inflammatory changes in the gastrointestinal tract characteristic of Crohn’s disease. However, histopathological examination did not show classical signs of the disease. The diagnosis of Crohn’s disease was made based on a comprehensive analysis of clinical manifestations and examination results.

Conclusions. Chronic inflammatory bowel diseases remain a diagnostic challenge in children due to their variable presentation. A meticulous evaluation of patient complaints and medical history, integrated with a comprehensive assessment of physical examination findings supported by auxiliary diagnostic methods, and guided by adherence to established diagnostic standards, minimizes the risk of misdiagnosis and supports the selection of the most appropriate treatment strategy.

Author Biographies

S. M. Nedelska, Zaporizhzhia State Medical and Pharmaceutical University

MD, PhD, DSc, Professor, Head of Department of Faculty Pediatrics

T. H. Bessikalo, Zaporizhzhia State Medical and Pharmaceutical University

MD, PhD, Assistant of the Department of Faculty Pediatrics

O. V. Liamtseva, Zaporizhzhia State Medical and Pharmaceutical University

MD, PhD student of the Department of Faculty Pediatrics

References

Peppercorn MA, Cheifetz AS. Definitions, epidemiology, and risk factors for inflammatory bowel disease. UpToDate [Internet]. 2025 Feb. 24 Available from: https://www.uptodate.com/contents/definitions-epidemiology-and-risk-factors-for-inflammatory-bowel-disease

Zitomersky N, Bousvaros A. Overview of the management of Crohn disease in children and adolescents. UpToDate [Internet]. 2025 Feb. 24 Available from: https://www.uptodate.com/contents/overview-of-the-management-of-crohn-disease-in-children-and-adolescents

GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17-30. doi: https://doi.org/10.1016/S2468-1253(19)30333-4

Agrawal M, Christensen HS, Bøgsted M, Colombel JF, Jess T, Allin KH. The Rising Burden of Inflammatory Bowel Disease in Denmark Over Two Decades: A Nationwide Cohort Study. Gastroenterology. 2022;163(6):1547-54.e5. doi: https://doi.org/10.1053/j.gastro.2022.07.062

Bancil AS, Sandall AM, Rossi M, Chassaing B, Lindsay JO, Whelan K. Food Additive Emulsifiers and Their Impact on Gut Microbiome, Permeability, and Inflammation: Mechanistic Insights in Inflammatory Bowel Disease. J Crohns Colitis. 2021;15(6):1068-79. doi: https://doi.org/10.1093/ecco-jcc/jjaa254

Nguyen LH, Örtqvist AK, Cao Y, Simon TG, Roelstraete B, Song M, et al. Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden. Lancet Gastroenterol Hepatol. 2020;5(11):986-95. doi: https://doi.org/10.1016/S2468-1253(20)30267-3

Oh SJ, Kim HJ, Lee CK; Big Data Research Group (BDRG) of the Korean Society of Gastroenterology. A dose-dependent increase in the risk of inflammatory bowel disease after exposure to broad-spectrum antibiotics: A national population study in Korea. Aliment Pharmacol Ther. 2023;58(2):191-206. doi: https://doi.org/10.1111/apt.17542

Narula N, Wong EC, Pray C, Marshall JK, Rangarajan S, Islam S, et al. Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study. Clin Gastroenterol Hepatol. 2023;21(10):2649-59.e16. doi: https://doi.org/10.1016/j.cgh.2022.11.037

Kuenzig ME, Fung SG, Marderfeld L, Mak JW, Kaplan GG, Ng SC, et al. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review. Gastroenterology. 2022;162(4):1147-59.e4. doi: https://doi.org/10.1053/j.gastro.2021.12.282

Additional Files

Published

2025-04-30

How to Cite

1.
Nedelska SM, Bessikalo TH, Liamtseva OV. Features of comprehensive diagnostics of Crohn’s disease in pediatric practice. Pathologia [Internet]. 2025Apr.30 [cited 2025May17];22(1):69-73. Available from: https://pat.zsmu.edu.ua/article/view/312416

Issue

Section

Case Reports